| Financial Year |
March 31 2023 |
| Monetary Funds |
599,855,547.45 |
| Held-for-trading Financial Assets |
454,700.00 |
| Notes Receivable |
5,935,644.00 |
| Accounts Receivable |
1,038,679,658.81 |
| Advances to Suppliers |
40,587,599.17 |
| Other Receivables |
27,141,380.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
518,674,920.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,880,825.04 |
| Total Current Assets |
2,511,516,385.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
333,728,929.24 |
| Investment Properties |
-- |
| Fixed Assetes |
439,118,242.04 |
| Under-construction Projects |
123,739,441.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,297,561.99 |
| R&D expenses |
10,159,617.06 |
| Goodwill |
227,994,616.82 |
| Long-Term Deferred and Prepaid Expenses |
1,558,875.89 |
| Deferred Income Tax Assets |
20,405,943.58 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,290,568,009.52 |
| Total Assets |
3,802,084,395.31 |
| Short-Term Loans |
332,253,923.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
197,203,294.86 |
| Accounts Payable |
358,464,621.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,274,335.05 |
| Taxes Payable |
22,542,869.73 |
| Interest Payable |
-- |
| Dividend Payable |
16,903,458.12 |
| Other payables |
510,754,505.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
749,424.19 |
| Other Current Liabilities |
9,185,215.38 |
| Sub-Total of Current Liabilities |
1,531,206,863.06 |
| Long-term Loans |
40,220,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,827,266.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,943,176.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
94,683,167.44 |
| Total Liabilities |
1,625,890,030.50 |
| Paid-In Capital(Or Share Stock) |
1,087,735,321.00 |
| Capital Surplus |
289,224,943.31 |
| Surplus Reserve |
64,755,193.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
557,699,116.20 |
| Minority Stockholder's Interest |
180,454,660.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,995,739,704.19 |
| Owner's Equity（Stockholder's Equity） |
2,176,194,364.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,802,084,395.31 |
